Cargando…
Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis
BACKGROUND: Antibodies against Ro-52 have been described in patients with a broad spectrum of autoimmune disease, most commonly in association with anti-Ro-60 in systemic lupus erythematosus and Sjogrens syndrome. However, in inflammatory myositis anti-Ro-52 is frequently present without anti-Ro-60...
Autores principales: | Parker, Jennifer C, Burlingame, Rufus W, Bunn, Christopher C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654555/ https://www.ncbi.nlm.nih.gov/pubmed/19267890 http://dx.doi.org/10.1186/1740-2557-6-2 |
Ejemplares similares
-
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
por: Hudson, Marie, et al.
Publicado: (2012) -
Highlights on Novel Technologies for the Detection of Antibodies to Ro60, Ro52, and SS-B
por: Infantino, M., et al.
Publicado: (2013) -
Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis
por: Gkoutzourelas, Athanasios, et al.
Publicado: (2018) -
Analysis of anti-Ro52 antibodies in sera of healthy subjects
por: Zimmermann, C, et al.
Publicado: (2001) -
Serological epitope profile of anti-Ro52–positive patients with systemic autoimmune rheumatic diseases
por: Infantino, Maria, et al.
Publicado: (2015)